BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25035066)

  • 1. Aberrant expression of p-Smad3 in oral carcinogenesis.
    Poomsawat S; Punyasingh J; Vejchapipat P
    Clin Oral Investig; 2015 Apr; 19(3):613-8. PubMed ID: 25035066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of survivin and caspase 3 in oral carcinogenesis.
    Poomsawat S; Punyasingh J; Vejchapipat P
    Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):65-71. PubMed ID: 23531848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma.
    Rahman R; Poomsawat S; Juengsomjit R; Buajeeb W
    BMC Oral Health; 2019 Jul; 19(1):142. PubMed ID: 31291930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p16 in oral cancer and premalignant lesions.
    Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
    J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of survivin, caspase-3 in oral precancerous lesions and oral squamous-cell carcinoma].
    Ding YP; Li SX; Wu HR; Zhang XY; Tang XF; Sun Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):85-8. PubMed ID: 20368001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia.
    Ishida K; Ito S; Wada N; Deguchi H; Hata T; Hosoda M; Nohno T
    Mol Cancer; 2007 Oct; 6():62. PubMed ID: 17922924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
    Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions.
    Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
    J Oral Pathol Med; 2010 Nov; 39(10):793-9. PubMed ID: 20618617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
    Routray S; Kheur SM; Kheur M
    Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias.
    Chen YK; Huang AH; Cheng PH; Yang SH; Lin LM
    Clin Oral Investig; 2013 Apr; 17(3):921-32. PubMed ID: 22669485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
    Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
    Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
    Palani J; Lakshminarayanan V; Kannan R
    Indian J Dent Res; 2011; 22(2):362. PubMed ID: 21891916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
    Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
    Guo ZL; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
    Brito JA; Gomes CC; Guimarães AL; Campos K; Gomez RS
    J Oral Pathol Med; 2014 Mar; 43(3):211-6. PubMed ID: 24020903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic potential of Type VII Collagen during oral carcinogenesis.
    Poomsawat S; Kariya A; Nimmanon T; Kosanwat T; Juengsomjit R; Sirima S
    J Appl Oral Sci; 2023; 31():e20220486. PubMed ID: 37194793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
    Xia RH; Song XM; Wang XJ; Li J; Mao L
    PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.